IMPROVEMENT WITH DULOXETINE IN PRIMARY PROGRESSIVE FREEZING GAITMORGANTE, Francesca; FASANO, Alfonso.Neurology. 2010, Vol 75, Num 23, pp 2130-2132, issn 0028-3878, 3 p.Article

Highly enantioselective bioreduction of N-methyl-3-oxo-3-(thiophen-2-yl) propanamide for the production of (S)-duloxetineTANG, Chuan-Gen; HUI LIN; CHAO ZHANG et al.Biotechnology letters. 2011, Vol 33, Num 7, pp 1435-1440, issn 0141-5492, 6 p.Article

Open-Label Support for Duloxetine for the Treatment of Panic DisorderSIMON, Naomi M; KAUFMAN, Rebecca E; HOGE, Elizabeth A et al.CNS neuroscience & therapeutics (Print). 2009, Vol 15, Num 1, pp 19-23, issn 1755-5930, 5 p.Article

Generalized tonic―clonic seizure secondary to duloxetine poisoning: A short report with favorable out comePELLICCIARI, Alessandro; BALZARRO, Beatrice; SCARAMELLI, Annarosa et al.Neurotoxicology (Park Forest South). 2012, Vol 33, Num 2, pp 189-190, issn 0161-813X, 2 p.Article

Duloxetine-Associated TachycardiaSTEVENS, Debra L.The Annals of pharmacotherapy. 2008, Vol 42, Num 10, pp 1511-1513, issn 1060-0280, 3 p.Article

Stress Degradation Studies and Kinetic Determinations of Duloxetine Enteric-Coated Pellets by HPLCGOMES, Patricia; WINGERT, Nathalie R; PAIM, Clésio S et al.Journal of AOAC International. 2010, Vol 93, Num 6, pp 1829-1835, issn 1060-3271, 7 p.Article

Stability-Indicating RP-HPLC Method Development and Validation for Duloxetine Hydrochloride in TabletsPATEL, Sejal K; PATEL, Natavarlal J; PRAJAPATI, Arun M et al.Journal of AOAC International. 2010, Vol 93, Num 1, pp 123-132, issn 1060-3271, 10 p.Article

NGF serum levels variations in major depressed patients receiving duloxetineMARTINO, Matteo; ROCCHI, Giulio; ESCELSIOR, Andrea et al.Psychoneuroendocrinology. 2013, Vol 38, Num 9, pp 1824-1828, issn 0306-4530, 5 p.Article

Clinical consequences of initial duloxetine dosing strategies : Comparison of 30 and 60 mg QD starting dosesDUNNER, David L; WOHLREICH, Madelaine M; MALLINCKRODT, Craig H et al.Current therapeutic research. 2005, Vol 66, Num 6, pp 522-540, issn 0011-393X, 19 p.Article

Single-agent duloxetine ingestionsJACOB, J; ALBERT, D; HEARD, K et al.Human & experimental toxicology. 2013, Vol 32, Num 4, pp 427-433, issn 0960-3271, 7 p.Article

Douleurs neuropathiques = Neuropathic painsATTAL, Nadine.Neurologie.com. 2010, Vol 2, Num 8, pp 202-205, issn 2100-9511, 4 p.Article

A 1-year Safety and Efficacy Study of Duloxetine in Patients With FibromyalgiaCHAPPELL, Amy S; LITTLEJOHN, Geoffrey; KAJDASZ, Daniel K et al.The Clinical journal of pain. 2009, Vol 25, Num 5, pp 365-375, issn 0749-8047, 11 p.Article

Isolation and characterisation of a phenolic impurity in a commercial sample of duloxetineBRENNA, Elisabetta; FRIGOLI, Samuele; FRONZA, Giovanni et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 43, Num 4, pp 1573-1575, issn 0731-7085, 3 p.Article

A dose-finding study of duloxetine based on serotonin transporter occupancyTAKANO, Akihiro; SUZUKI, Kazutoshi; KOSAKA, Jun et al.Psychopharmacologia. 2006, Vol 185, Num 3, pp 395-399, issn 0033-3158, 5 p.Article

Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorderBECH, Per; KAJDASZ, Daniel K; PORSDAL, Vibeke et al.Psychopharmacologia. 2006, Vol 188, Num 3, pp 273-280, issn 0033-3158, 8 p.Article

Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgroundsFORNARO, Michele; ROCCHI, Giulio; ESCELSIOR, Andrea et al.Journal of affective disorders. 2013, Vol 145, Num 3, pp 300-307, issn 0165-0327, 8 p.Article

VEGF plasma level variations in duloxetine-treated patients with major depressionFORNARO, Michele; ROCCHI, Giulio; ESCELSIOR, Andrea et al.Journal of affective disorders. 2013, Vol 151, Num 2, pp 590-595, issn 0165-0327, 6 p.Article

Duloxétine: concentrations sanguines post-mortem = Duloxetine: post-mortem blood concentrationsHOIZEY, Guillaume; DEVEAUX, Marc; CHEZE, Marjorie et al.Annales de toxicologie analytique. 2010, Vol 22, Num 1, pp 41-43, issn 0768-598X, 3 p.Article

Successful duloxetine treatment of a binge eating disorder: a case reportBERNARDI, S; PALLANTI, S.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 8, pp 1269-1272, issn 0269-8811, 4 p.Article

Lipase mediated resolution of γ-azidoalcohols in aqueous and organic media : Synthesis of (R)-and (S)-fluoxetine and duloxetineKAMAL, Ahmed; SHAHEER MALIK, M; AHMAD ALI SHAIK et al.Journal of molecular catalysis. B, Enzymatic. 2009, Vol 58, Num 1-4, pp 132-137, issn 1381-1177, 6 p.Article

Use of Duloxetine in Pregnancy and LactationBRIGGS, Gerald G; AMBROSE, Peter J; ILETT, Kenneth F et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 11, pp 1898-1902, issn 1060-0280, 5 p.Article

Duloxetine for the treatment of major depressive disorder : A closer look at efficacy and safety data across the approved dose rangeMALLINCKRODT, Craig H; PRAKASH, Apurva; ANDORN, Anne C et al.Journal of psychiatric research. 2006, Vol 40, Num 4, pp 337-348, issn 0022-3956, 12 p.Article

Controlled comparison of two different doses of milnacipran in major depressive outpatientsKANEMOTO, Kousuke; MATSUBARA, Momoyo; YAMASHITA, Koichi et al.International clinical psychopharmacology. 2004, Vol 19, Num 6, pp 343-346, issn 0268-1315, 4 p.Article

Pharmacogenetic workup of perioperative serotonin syndromeBEATTY, Nicole C; NICHOLSON, Wayne T; LANGMAN, Loralie J et al.Journal of clinical anesthesia. 2013, Vol 25, Num 8, pp 662-665, issn 0952-8180, 4 p.Article

Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studiesOAKES, Tina M; KATONA, Cornelius; PENG LIU et al.International clinical psychopharmacology. 2013, Vol 28, Num 1, pp 1-11, issn 0268-1315, 11 p.Article